InvestorsHub Logo
Followers 1326
Posts 248605
Boards Moderated 64
Alias Born 12/07/2009

Re: None

Tuesday, 04/04/2023 3:30:44 PM

Tuesday, April 04, 2023 3:30:44 PM

Post# of 113
$ORGS We believe that by offering a more cost-effective drug development pathway for these therapies, especially for companies trying to optimize cash utilization, we can offer new cost-efficient solution that will unlock value not only for Orgenesis, but across the industry.

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORGS News